Cargando…
Inducing immunogenic cell death in immuno-oncological therapies
Immunotherapy has revolutionized cancer treatment and substantially improved patient outcomes with respect to multiple types of tumors. However, most patients cannot benefit from such therapies, mainly due to the intrinsic low immunogenicity of cancer cells (CCs) that allows them to escape recogniti...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913252/ https://www.ncbi.nlm.nih.gov/pubmed/35355932 http://dx.doi.org/10.21147/j.issn.1000-9604.2022.01.01 |